Suffolk Breast Imaging Redefines Routine Mammography with CureMetrix's cmAngio®

Long Island breast imaging practice enhances routine screening mammography with AI-powered Breast Arterial Calcification detection

SAN DIEGO, CA, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- CureMetrix today announced that Suffolk Breast Imaging, a trusted provider of breast imaging services serving Suffolk County, Long Island since 1985, has added cmAngio^®, the first FDA-cleared AI solution for Breast Arterial Calcification (BAC) detection and localization, to its breast imaging services. Known for combining specialized breast imaging expertise with compassionate, personalized care, Suffolk Breast Imaging continues its commitment to bringing advanced technology to every patient while enhancing the value of routine screening mammography.

cmAngio identifies BAC from the same mammogram used for breast cancer screening, providing radiologists with additional clinical insight without requiring additional imaging, radiation, appointments, or changes to standard mammography workflows. The AI solution integrates seamlessly into existing clinical workflows, helping providers get more from every routine screening exam.

"At Suffolk Breast Imaging, we've always believed that combining experienced breast imaging specialists with advanced technology leads to better care for our patients," said Dr. Alexandra Perkins, Suffolk Breast Imaging. "Adding cmAngio allows us to gain additional clinical insight from the screening mammograms our patients are already receiving while maintaining the personalized, high-quality experience our practice has delivered for more than four decades."

Located in Lake Grove, New York, Suffolk Breast Imaging has built its reputation on delivering expert breast imaging in a welcoming, patient-focused environment. The practice offers comprehensive women's imaging services, including screening and diagnostic mammography, breast ultrasound, image-guided breast biopsy, and bone density testing. By incorporating advanced AI technologies into its imaging program, Suffolk Breast Imaging continues to invest in innovations that support both radiologists and patients throughout the screening experience.

"We're proud to partner with practices like Suffolk Breast Imaging that share our commitment to innovation and exceptional patient care," said Kevin Harris, President of CureMetrix. "Their dedication to combining specialized breast imaging expertise with leading AI technologies makes them an ideal partner as we continue expanding access to cmAngio. Together, we're helping providers deliver even greater value from the mammograms women already receive every year."

About CureMetrix
CureMetrix is advancing women's health through AI-powered imaging solutions designed to help clinicians detect what matters. Founded in 2014 on the belief that artificial intelligence can close the gap between what medicine is capable of and what patients actually receive, CureMetrix develops precision AI that integrates into existing workflows and delivers earlier answers, greater certainty, and additional clinical insight. The company's mission is to help save lives by improving disease detection and extending the value of screening programs worldwide. www.curemetrix.com

About Suffolk Breast Imaging
Since 1985, Suffolk Breast Imaging has provided specialized breast imaging services to women throughout Suffolk County and Long Island. Located in Lake Grove, New York, the practice is focused on breast imaging and women's health, offering screening and diagnostic mammography, breast ultrasound, breast biopsy, bone density testing, and additional imaging services. By combining experienced breast radiologists, advanced imaging technology, and personalized patient care, Suffolk Breast Imaging is committed to delivering a comfortable, compassionate imaging experience while supporting the early detection of breast disease. www.suffolkimaging.net

+1 858-333-5830
email us here
CureMetrix
CureMetrix
Visit us on social media:
LinkedIn
Facebook
X